Who invested in Blaze Bioscience

4 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Follow Blaze Bioscience and see its new rounds in your feed.Start following

Funding summaryUpdated 31 Oct 2026

$23Mraised across 4 rounds since 2011, from 4 sources

$725KDebt$5.0MSeries A$8.5MSeries A$9.0MSeries B

Latest round: Series B, $9.0MDec 2013
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20122013

$725KDebt$5.0MSeries A$8.5MSeries A$9.0MSeries B

First round: Debt, $725K
Biggest round: $9.0M
Usual gap between rounds: 9 months

The rounds

Dec 2013
Series B$9.0M
No investor was named in the report.
Reported by finsmes.com
Feb 2013
Series A$8.5M
No investor was named in the report.
Reported by finsmes.com
Jun 2012
Series A$5.0M
No investor was named in the report.
Reported by blazebioscience.comSEC filing: $6.4M sold, first sale Jun 2012
Oct 2011
Debt$725K
No investor was named in the report.
Reported by sec.govSEC filing: $725K sold, first sale Oct 2011

Founders and team

From Blaze Bioscience's own website: 2 on the team.

Christina WalkerHead of CMC
Damon MattsonHead of Quality

AdvisersRegulatory Affairs Key Advisor

Also claim to have backed them

These 2 firms list Blaze Bioscience as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.